$CBIH News

CBIH Evaluates a Potential Reg A Offering of Approximately $1,000,000 to Enable Commercial Launch, Statewide Educational Expansion, and Protection of Its Patent Portfolio

CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz's Team and an "Evidence Sprint 2026" Focused on Grants, Research and Clinical Evidence

CBIH Launches Federal and Pharmaceutical Outreach Initiative to Accelerate Medical Cannabis Research in the Schedule III Transition

CBIH Announces New Patent Initiative Targeting Opioid Addiction Through Endocannabinoid Pathways

CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities

CBIH: Potential Rescheduling to Schedule III Could Reward Decades of Scientific Preparation and Regulatory Discipline

CBIH Announces Women-First Fertility Innovation Built on Nanoemulsion Delivery

Cannabis Bioscience International Holdings, Inc. Appoints Veteran Financier Andy Trivedi to Its Board of Directors, Strengthening Capital Strategy and Growth Outlook

CBIH Ignites Texas: Statewide TCUP Seminar Marks a New Era for Medical Cannabis-With Evidence, Safety, and Patient Dignity at the Center

Brian Cuban to Represent CBIH in DEA Hearings on Marijuana Reclassification

Cannabis Bioscience International Holdings (CBIH) Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products

CBIH Files Petition to Include Alexis Bortell as Witness in DEA Rescheduling Hearing

A Letter from the Desk of CBIH

CBIH Advocates for Cannabis Policy Reform at DEA Reclassification Hearing

CBIH Unveils the Future of Wellness with Revolutionary Anti-Aging Chip

CBIH Strengthens Clinical Research Team in Preparation for Launch of Next-Generation Cannabinoid Solutions

Cannabis Bioscience International Holdings Selected to Participate in DEA Hearing on Cannabis Rescheduling Docket No. 1362 and Hearing Docket No. 24-44

CBIH Welcomes Charles Tamburello to Its Board, Strengthening M&A Strategy

CBIH Strengthens Competitive Advantage with Rapid Expansion of Patent Filings

CBIH Pursues Regulatory Compliance and Market Growth with Essential Licensing Applications